Variant report
Variant | esv3338702 |
---|---|
Chromosome Location | chr2:77034244-77035242 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs76772802 | chr2:77034279-77034280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187189748 | chr2:77034325-77034326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143683199 | chr2:77034360-77034361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs146789264 | chr2:77034361-77034362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs534165934 | chr2:77034373-77034374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140458175 | chr2:77034386-77034387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs574095690 | chr2:77034388-77034389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs202201400 | chr2:77034464-77034465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs67091611 | chr2:77034465-77034466 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs556184860 | chr2:77034466-77034467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs200287880 | chr2:77034468-77034469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs72919678 | chr2:77034505-77034506 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs72365054 | chr2:77034509-77034510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs199899319 | chr2:77034524-77034525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs7560540 | chr2:77034526-77034527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs7574473 | chr2:77034527-77034528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs7560323 | chr2:77034533-77034534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs201823083 | chr2:77034534-77034535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs7574478 | chr2:77034539-77034540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs13410040 | chr2:77034549-77034550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs368842956 | chr2:77034551-77034552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs72421749 | chr2:77034552-77034553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs376026235 | chr2:77034553-77034554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370485197 | chr2:77034555-77034556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs199795965 | chr2:77034561-77034562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs70939835 | chr2:77034562-77034563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs371747340 | chr2:77034563-77034564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs375172177 | chr2:77034564-77034565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs372745798 | chr2:77034571-77034572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs181031637 | chr2:77034583-77034584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs62172135 | chr2:77034585-77034586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs62172136 | chr2:77034595-77034596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs545039725 | chr2:77034597-77034598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs143367668 | chr2:77034598-77034599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs190001667 | chr2:77034599-77034600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs111512293 | chr2:77034602-77034603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544913687 | chr2:77034613-77034614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs182587500 | chr2:77034615-77034616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs116214630 | chr2:77034665-77034666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201383788 | chr2:77034684-77034685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs374096896 | chr2:77034714-77034715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs541996994 | chr2:77034719-77034720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs571835548 | chr2:77034754-77034755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542330352 | chr2:77034762-77034763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554016038 | chr2:77034775-77034776 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs139235738 | chr2:77034776-77034777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs111233814 | chr2:77034811-77034812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372603189 | chr2:77034830-77034831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs531211448 | chr2:77034842-77034843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs140593639 | chr2:77034880-77034881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
Epilepsy | 22083797 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:77009000-77039000 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
2 | chr2:77009600-77038200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr2:77035000-77037000 | Enhancers | Fetal Lung | lung |
4 | chr2:77035200-77035400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |